|
TWI707038B
(zh)
|
2013-08-05 |
2020-10-11 |
美商扭轉生物科技有限公司 |
重新合成之基因庫
|
|
WO2016126882A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
US9981239B2
(en)
|
2015-04-21 |
2018-05-29 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
KR20180050411A
(ko)
|
2015-09-18 |
2018-05-14 |
트위스트 바이오사이언스 코포레이션 |
올리고핵산 변이체 라이브러리 및 그의 합성
|
|
CN108698012A
(zh)
|
2015-09-22 |
2018-10-23 |
特韦斯特生物科学公司 |
用于核酸合成的柔性基底
|
|
WO2017095958A1
(en)
|
2015-12-01 |
2017-06-08 |
Twist Bioscience Corporation |
Functionalized surfaces and preparation thereof
|
|
DK3430030T5
(da)
|
2016-03-16 |
2024-09-23 |
Immatics Biotechnologies Gmbh |
Transficerede t-celler og t-cellereceptorer til anvendelse i immunoterapi mod cancer
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
KR102212257B1
(ko)
|
2016-08-22 |
2021-02-04 |
트위스트 바이오사이언스 코포레이션 |
드 노보 합성된 핵산 라이브러리
|
|
WO2018057526A2
(en)
|
2016-09-21 |
2018-03-29 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
RS62865B1
(sr)
|
2016-12-08 |
2022-02-28 |
Immatics Biotechnologies Gmbh |
Novi t-ćelijski receptori i imunoterapija u kojoj se koriste
|
|
DE102016123847B3
(de)
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
EP3554514A4
(en)
|
2016-12-16 |
2020-08-05 |
Twist Bioscience Corporation |
BANKS OF VARIANTS OF IMMUNOLOGICAL SYNAPSE AND THEIR SYNTHESIS
|
|
CN110892485B
(zh)
|
2017-02-22 |
2024-03-22 |
特韦斯特生物科学公司 |
基于核酸的数据存储
|
|
AU2018234629A1
(en)
|
2017-03-15 |
2019-10-17 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
EP3609530A1
(en)
*
|
2017-04-10 |
2020-02-19 |
Immatics Biotechnologies GmbH |
Peptides and combination thereof for use in the immunotherapy against cancers
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
JP7169999B2
(ja)
|
2017-06-12 |
2022-11-11 |
ツイスト バイオサイエンス コーポレーション |
シームレス核酸アセンブリのための方法
|
|
AU2018328847A1
(en)
|
2017-09-11 |
2020-04-23 |
Twist Bioscience Corporation |
GPCR binding proteins and synthesis thereof
|
|
US11598780B2
(en)
*
|
2017-10-06 |
2023-03-07 |
The University Of Chicago |
Engineering lymphocytes with specific alpha and beta chains on their t-cell receptor
|
|
CA3081336A1
(en)
|
2017-10-12 |
2019-04-18 |
Gregory LIZEE |
T cell receptors for immunotherapy
|
|
WO2019079769A1
(en)
|
2017-10-20 |
2019-04-25 |
Twist Bioscience Corporation |
HEATED NANOWELLS FOR THE SYNTHESIS OF POLYNUCLEOTIDES
|
|
EP4715681A2
(en)
|
2018-01-04 |
2026-03-25 |
Atlas Data Storage, Inc. |
Dna-based digital information storage
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
WO2019196088A1
(en)
*
|
2018-04-13 |
2019-10-17 |
Syz Cell Therapy Co. |
Methods of obtaining tumor-specific t cell receptors
|
|
IL278771B2
(en)
|
2018-05-18 |
2025-09-01 |
Twist Bioscience Corp |
Polynucleotides, reagents and methods for nucleic acid hybridization
|
|
JP7558151B2
(ja)
*
|
2018-09-05 |
2024-09-30 |
アダプティミューン・リミテッド |
Ｔ細胞改変
|
|
MA53599A
(fr)
*
|
2018-09-14 |
2021-07-21 |
Immatics Biotechnologies Gmbh |
Procédé de criblage par affinité peptide-cmh à haut débit destiné à des ligands de tcr
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
CN112912391A
(zh)
*
|
2018-10-25 |
2021-06-04 |
昆士兰医学研究所理事会 |
T细胞受体及其用途
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
WO2020139871A1
(en)
|
2018-12-26 |
2020-07-02 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
AU2020227802A1
(en)
|
2019-02-26 |
2021-10-14 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for antibody optimization
|
|
WO2020176678A1
(en)
|
2019-02-26 |
2020-09-03 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for glp1 receptor
|
|
WO2020191172A1
(en)
|
2019-03-19 |
2020-09-24 |
Immatics US, Inc. |
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
DE102019108125B4
(de)
|
2019-03-28 |
2022-02-03 |
Immatics US, Inc. |
Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
CN111748028A
(zh)
*
|
2019-03-29 |
2020-10-09 |
天津亨佳生物科技发展有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN111748029B
(zh)
*
|
2019-03-29 |
2022-12-13 |
苏州蓝马医疗技术有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
MX2021013588A
(es)
*
|
2019-05-08 |
2022-02-11 |
Medigene Immunotherapies Gmbh |
Células t genomodificadas.
|
|
MA56036A
(fr)
|
2019-05-27 |
2022-04-06 |
Immatics Us Inc |
Vecteurs viraux et leur utilisation dans une thérapie cellulaire adoptive
|
|
CN118994364A
(zh)
*
|
2019-06-18 |
2024-11-22 |
里珍纳龙药品有限公司 |
Mage-a4 t细胞受体及其使用方法
|
|
EP3986450A4
(en)
*
|
2019-06-20 |
2023-06-28 |
Memorial Sloan Kettering Cancer Center |
T cell receptors targeting pik3ca mutations and uses thereof
|
|
CA3144644A1
(en)
|
2019-06-21 |
2020-12-24 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
CN110357953B
(zh)
*
|
2019-07-17 |
2022-05-03 |
深圳市因诺转化医学研究院 |
识别人巨细胞病毒pp65抗原的TCR
|
|
WO2021019474A1
(en)
*
|
2019-07-30 |
2021-02-04 |
University Health Network |
Mhc class ii molecules and methods of use thereof
|
|
DE102019121007A1
(de)
*
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
US12091777B2
(en)
|
2019-09-23 |
2024-09-17 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for CRTH2
|
|
EP4034564A4
(en)
|
2019-09-23 |
2023-12-13 |
Twist Bioscience Corporation |
VARIANT NUCLEIC ACID LIBRARIES FOR SINGLE-DOMAIN ANTIBODIES
|
|
BR112022011235A2
(pt)
|
2019-12-09 |
2022-12-13 |
Twist Bioscience Corp |
Bibliotecas de variantes de ácido nucleico para receptores de adenosina
|
|
AU2021206644A1
(en)
*
|
2020-01-06 |
2022-07-28 |
Memorial Hospital For Cancer And Allied Diseases |
Novel dominant negative Fas polypeptides, cells comprising thereof and uses thereof
|
|
AU2021225817A1
(en)
|
2020-02-24 |
2022-10-20 |
Immatics US, Inc. |
Methods for expanding T cells for the treatment of cancer and related malignancies
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
CN113621070A
(zh)
*
|
2020-05-06 |
2021-11-09 |
华夏英泰（北京）生物技术有限公司 |
一种t细胞抗原受体、其多聚体复合物及其制备方法和应用
|
|
US20220056411A1
(en)
*
|
2020-08-21 |
2022-02-24 |
Immatics US, Inc. |
Methods for isolating cd8+ selected t cells
|
|
JP7644421B2
(ja)
*
|
2020-10-07 |
2025-03-12 |
ダアン バイオセラピュティクス カンパニー、リミテッド |
Ｔ細胞受容体、ｔ細胞受容体を含む免疫細胞およびそれを用いる方法｛ｔ ｃｅｌｌ ｒｅｃｅｐｔｏｒｓ、ｉｍｍｕｎｅ ｃｅｌｌ ｃｏｍｐｒｉｓｉｎｇ ｔ ｃｅｌｌ ｒｅｃｅｐｔｏｒｓ ａｎｄ ｍｅｔｈｏｄ ｕｓｉｎｇ ｔｈｅ ｓａｍｅ｝
|
|
PE20250846A1
(es)
|
2020-12-31 |
2025-03-21 |
Immatics Us Inc |
Polipeptidos cd8, composiciones y metodos de uso de estos
|
|
DE102021100038A1
(de)
|
2020-12-31 |
2022-06-30 |
Immatics US, Inc. |
Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung
|
|
CN115975003B
(zh)
*
|
2021-03-09 |
2024-01-26 |
科士华(南京)生物技术有限公司 |
Tcr、多肽、表达载体、宿主细胞、药物组合物和tcr获得方法
|
|
KR20230159851A
(ko)
*
|
2021-03-22 |
2023-11-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
치료 세포 조성물의 효력을 결정하는 방법
|
|
WO2022225836A1
(en)
*
|
2021-04-21 |
2022-10-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hla class i-restricted t cell receptors against ras with q61k mutation
|
|
BR112023022975A2
(pt)
|
2021-05-05 |
2024-01-23 |
Immatics Biotechnologies Gmbh |
Polipeptídeos de ligação ao antígeno bma031 melhorados
|
|
CN113337514B
(zh)
*
|
2021-08-05 |
2021-10-29 |
卡瑞济(北京)生命科技有限公司 |
Tcr表达构建体以及其制备方法和用途
|
|
WO2023044488A1
(en)
|
2021-09-20 |
2023-03-23 |
Immatics US, Inc. |
Monocyte depletion of t cells populations for t-cell therapy
|
|
CN113773378B
(zh)
*
|
2021-10-14 |
2023-11-03 |
深圳大学总医院 |
T细胞受体及其应用
|
|
EP4414388A4
(en)
*
|
2021-11-03 |
2025-10-29 |
Curon Biopharmaceutical Shanghai Co Ltd |
NEW ANTI-L1CAM ANTIBODY
|
|
WO2023081461A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics US, Inc. |
Methods for generating cell spheroids
|
|
US20230192886A1
(en)
|
2021-11-08 |
2023-06-22 |
Immatics Biotechnologies Gmbh |
Adoptive cell therapy combination treatment and compositions thereof
|
|
US20250134999A1
(en)
|
2022-01-14 |
2025-05-01 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene activation
|
|
CA3247927A1
(en)
|
2022-01-14 |
2023-07-20 |
Tune Therapeutics, Inc. |
Compositions, systems and methods for programming T-lymphocyte phenotypes by targeted gene repression
|
|
EP4472742A1
(en)
*
|
2022-02-03 |
2024-12-11 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023183758A2
(en)
*
|
2022-03-19 |
2023-09-28 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules targeting cd3 and mage-a4 and uses thereof
|
|
EP4514821A1
(en)
|
2022-04-28 |
2025-03-05 |
Immatics US, Inc. |
Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof
|
|
IL316515A
(en)
|
2022-04-28 |
2024-12-01 |
Immatics Us Inc |
Membrane-bound IL15 CD8 proteins, cells, compositions and methods for their use
|
|
EP4514834A1
(en)
|
2022-04-28 |
2025-03-05 |
Immatics US, Inc. |
Dominant negative tgfbeta receptor polypeptides, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
US20230355678A1
(en)
|
2022-05-05 |
2023-11-09 |
Immatics US, Inc. |
Methods for improving t cell efficacy
|
|
EP4543911A2
(en)
*
|
2022-06-24 |
2025-04-30 |
Amgen Inc. |
Magea4 specific t cell receptors
|
|
US20260055158A1
(en)
*
|
2022-08-08 |
2026-02-26 |
The University Of North Carolina At Chapel Hill |
Bioorthogonal t cell receptor molecules and methods of making and using the same
|
|
WO2024064642A2
(en)
|
2022-09-19 |
2024-03-28 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for modulating t cell function
|
|
WO2025029835A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for modulating il-2 gene expression
|
|
WO2025029840A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for multiplexed activation and repression of t cell gene expression
|
|
WO2025096649A1
(en)
|
2023-11-01 |
2025-05-08 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2025233432A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use and dosage of an antigen-binding protein comprising a tcr specific for an hla-a*02 restricted peptide
|
|
WO2026008886A1
(en)
|
2024-07-05 |
2026-01-08 |
Immatics Biotechnologies Gmbh |
Means and methods for the quantification of target expression
|
|
WO2026082746A1
(en)
|
2024-10-14 |
2026-04-23 |
Immatics Biotechnologies Gmbh |
Bispecific molecule formulation
|